Cargando…

Antagonizing the effects of Bst-2/tetherin: multiple ways to accomplish a common goal

Detalles Bibliográficos
Autor principal:	Strebel, Klaus
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766940/ http://dx.doi.org/10.1186/1742-4690-6-S2-I10

Ejemplares similares

Antagonism to human BST-2/tetherin by Sendai virus glycoproteins
por: Bampi, Carole, et al.
Publicado: (2013)

Structural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral Antagonism
por: Arias, Juan F., et al.
Publicado: (2011)

Ebolavirus Replication and Tetherin/BST-2
por: Yasuda, Jiro
Publicado: (2012)

Tetherin/BST-2 Antagonism by Nef Depends on a Direct Physical Interaction between Nef and Tetherin, and on Clathrin-mediated Endocytosis
por: Serra-Moreno, Ruth, et al.
Publicado: (2013)

The long way from bench to bedside
por: Gaide, Olivier
Publicado: (2012)

BST2/Tetherin Enhances Entry of Human Cytomegalovirus
por: Viswanathan, Kasinath, et al.
Publicado: (2011)

The avian influenza virus PA segment mediates strain-specific antagonism of BST-2/tetherin
por: Narkpuk, Jaraspim, et al.
Publicado: (2018)

The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu
por: Andrew, Amy J, et al.
Publicado: (2009)

Restriction of Retroviral Replication by Tetherin/BST-2
por: Hammonds, Jason, et al.
Publicado: (2012)

BST2/Tetherin Inhibition of Alphavirus Exit
por: Ooi, Yaw Shin, et al.
Publicado: (2015)

Feline tetherin (BST-2) restricts feline immunodeficiency virus release but not spreading infection
por: Dietrich, Isabelle, et al.
Publicado: (2011)

The Great Escape: Viral Strategies to Counter BST-2/Tetherin
por: Douglas, Janet L., et al.
Publicado: (2010)

Deciphering the genetic basis of common diseases by integrated functional annotation of common and rare variants
por: Harismendy, Olivier, et al.
Publicado: (2010)

A common protein export pathway in malaria parasites
por: Crabb, Brendan, et al.
Publicado: (2010)

Tetherin antagonism by HIV-1 and its SIV precursors
por: Kirchhoff, Frank
Publicado: (2011)

Cloning and Characterization of the Antiviral Activity of Feline Tetherin/BST-2
por: Fukuma, Aiko, et al.
Publicado: (2011)

The role of BST‐2/Tetherin in host protection and disease manifestation
por: Mahauad‐Fernandez, Wadie D., et al.
Publicado: (2015)

How to manage multiple food allergies in children
por: Lau, Susanne
Publicado: (2011)

How to manage multiple food allergies in children
por: Venter, Carina
Publicado: (2011)

Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation
por: Lv, Mingyu, et al.
Publicado: (2015)

Division of labor: multiple and specialized controls of vegetative growth and development in a poplar tree
por: Busov, Victor, et al.
Publicado: (2011)

Resilience of BST-2/Tetherin structure to single amino acid substitutions
por: Roy, Ian R., et al.
Publicado: (2019)

Identification of Residues in the BST-2 TM Domain Important for Antagonism by HIV-1 Vpu Using a Gain-of-Function Approach
por: Yoshida, Takeshi, et al.
Publicado: (2011)

Tetherin and Its Viral Antagonists
por: Kuhl, Björn D., et al.
Publicado: (2011)

Adverse effects
por: Evans, Stephen JW
Publicado: (2011)

Antiviral Inhibition of Enveloped Virus Release by Tetherin/BST-2: Action and Counteraction
por: Le Tortorec, Anna, et al.
Publicado: (2011)

Immunological and clinical effects of probiotics
por: Eigenmann, Philippe
Publicado: (2011)

Immunotherapy of food allergy: what is effective?
por: Renz, Harald
Publicado: (2011)

Immunotherapy of food allergy: what is effective?
por: Sampson, Hugh
Publicado: (2011)

Benefits of effective diagnosis on impact of quality of life
por: Dubois, Anthony T
Publicado: (2011)

Effects of glyceryl trinitrate and calcitonin-gene-related peptide on BOLD signal and arterial diameter –methodological studies by fMRI and MRA
por: Asghar, MS, et al.
Publicado: (2013)

Structure function analysis of P. falciparum VAR2CSA
por: Dahlbäck, Madeleine, et al.
Publicado: (2010)

PReS13-SPK-1277: Role of ß2GPI in APS
por: De Groot, PP
Publicado: (2013)

S41. Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer
por: Klein, C
Publicado: (2014)

BST2/Tetherin Inhibits Dengue Virus Release from Human Hepatoma Cells
por: Pan, Xiao-Ben, et al.
Publicado: (2012)

Analysis of 2,440 human exomes highlights the evolution and functional impact of rare coding variation
por: Akey, Joshua
Publicado: (2011)

S2. Therapeutic strategies based on overcoming immune resistance mechanisms within the melanoma tumour microenvironment
por: Gajewski, T
Publicado: (2014)

A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum
por: Ward, Steve A, et al.
Publicado: (2010)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fc38akafjsjdfrlq03eskg09g9